I know I'm a pessimist, but what does the following mean to you?
"The agreement calls for Biomedix Corp. to distribute a minimum 12,600 units of the F.A.S.T.1 System over a 24-month period in the Canadian marketplace." That's 6,300 minimum per year, or $63,000 in revenue per year. The goals aren't what people expected. They're more in line with what I have been predicting - a nickel and dime business for the first few years. Mind you, I guess there will be equal or better business coming in from the States. So maybe we'll see $150,000 to $200,000 in revenue for next year. It's small, but I guess it's a start. Personally, I think the stock is being taken up superficially in order to allow for a private placement at a higher price. A company should not be valued at over $20 million ($1.70/share) if they're only going to do one tenth of that in revenue, and maybe 5% in net profit. So why the high stock price, less dilution from a future placement? I think so. I'm not going to buy at this level. I'm a patient man. When the disappointing order #'s reveal themselves over the next 12 months, I'll start to accumulate between $1.25 and $1.50, which I think is too high, but this market is screwy, and in turn, I can't see it falling below a $1.25. Good luck to all. |
